Hiring?
Logo

Nanovery

Short Summary

We are developing Nanorobots for early cancer detection, making it 10× cheaper and 100× faster than the current best detection method. Our nanorobots can capture cancer biomarkers in a patient's blood sample and light up to signal a positive result.

Overview

Target
£1,000,000
Minimum
£25,000
Investment Raised
£400,000
Previous Rounds £80,000
Stage Pre-Startup/R&D
Investor Role Any

Highlights

  • Excellent and experienced team supported by world-class advisors
  • Working prototype ready and periodically refined based on user feedback
  • Pilot with the Newcastle Cancer Centre and testing on clinical samples
  • Recipient of Roche's "Future X Healthcare 2019 Start-up" Award
  • In contact with a number of global pharmaceutical companies
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
30% raised

Occuity

location_on South East, United Kingdom

Occuity; Developed a patented, highly innovative, non-contact technology to detect & monitor chronic diseases; Targeting a $14bn market; Prototypes ready & successfully tested; 100+ yrs combined team experience; EIS eligibility; Already raised £300k...

£ 1,000,000

Target

£ 5,000

Min per Investor

Global Pro
66% raised

LiveSmart

location_on London, United Kingdom

Digital platform for preventative healthcare. £60k revenue per month forecasting £1.7m this year. Trusted by Vita Coco, AXA, Universal, Gazprom and Skyscanner. 75% of their revenue is from repeat business. Expanding to Asia imminently.

£ 1,500,000

Target

£ 25,000

Min per Investor

Global Pro
60% raised

Ampersand Health

location_on London, United Kingdom

Ampersand Health is a digital medicine platform improving treatment of inflammatory condition. Revenue generating, they have 14,000 patients signed-up and integrations with 15 hospitals. The Founder has 2 previous exits including 1 in digital health.

£ 1,000,000

Target

£ 25,000

Min per Investor

load one similar proposal